We are live on ! Find out more
PCMI

Paradigm Capital Management Inc Portfolio holdings

AUM $2.61B
1-Year Est. Return 78.58%
This Fund
S&P 500
This Quarter Est. Return
-18.87%
1 Year Est. Return
+78.58%
3 Year Est. Return
+164.7%
5 Year Est. Return
+201.05%
10 Year Est. Return
+1,210.21%
AUM
$1.47B
AUM Growth
-$377M
Cap. Flow
+$11.4M
Cap. Flow %
0.77%
Top 10 Hldgs %
35.59%
Holding
155
New
2
Increased
28
Reduced
47
Closed
7

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$12.7M
2
CERS icon
Cerus
CERS
+$5.26M
3
ICHR icon
Ichor Holdings
ICHR
+$3.88M
4
MTCH icon
Match Group
MTCH
+$1.89M
5
JILL icon
J. Jill
JILL
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 57.35%
2 Industrials 15.74%
3 Healthcare 12.53%
4 Consumer Discretionary 9.3%
5 Materials 2.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XGN icon
126
Exagen
XGN
$166M
$466K 0.03%
81,189
+24,289
+43% +$141K
IVC
127
DELISTED
Invacare Corporation
IVC
$448K 0.03%
350,000
+250,000
+250% +$329K
PG icon
128
Procter & Gamble
PG
$339B
$446K 0.03%
3,100
HALO icon
129
Halozyme
HALO
$12.2B
$440K 0.03%
10,000
CRS icon
130
Carpenter Technology
CRS
$28.4B
$385K 0.03%
13,800
ATI icon
131
ATI
ATI
$31B
$358K 0.02%
15,750
TRHC
132
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$355K 0.02%
138,100
+50,000
+57% +$188K
BAX icon
133
Baxter International
BAX
$14.2B
$340K 0.02%
5,300
BHC icon
134
Bausch Health
BHC
$2.34B
$334K 0.02%
40,000
+20,000
+100% +$280K
MRIN
135
DELISTED
Marin Software
MRIN
$330K 0.02%
33,333
+16,666
+100% +$213K
EBS icon
136
Emergent Biosolutions
EBS
$248M
$310K 0.02%
10,000
MDRX
137
DELISTED
Veradigm Inc. Common Stock
MDRX
$297K 0.02%
20,000
VISN
138
Vistance Networks Inc
VISN
$2.52B
$293K 0.02%
47,900
PEP icon
139
PepsiCo
PEP
$190B
$283K 0.02%
1,700
PNTG icon
140
Pennant Group
PNTG
$1.36B
$256K 0.02%
20,000
OOMA icon
141
Ooma
OOMA
$604M
$237K 0.02%
20,000
RTX icon
142
RTX Corp
RTX
$301B
$224K 0.02%
2,334
NUS icon
143
Nu Skin
NUS
$267M
$216K 0.01%
5,000
ADEA icon
144
Adeia
ADEA
$3.11B
$189K 0.01%
49,612
OCUL icon
145
Ocular Therapeutix
OCUL
$2.02B
$161K 0.01%
40,000
MDXG icon
146
MiMedx Group
MDXG
$633M
$149K 0.01%
+43,000
New +$168K
CRNT icon
147
Ceragon Networks
CRNT
$201M
$90K 0.01%
35,000
EXPR
148
DELISTED
Express, Inc.
EXPR
$75K 0.01%
1,920
AMAT icon
149
Applied Materials
AMAT
$428B
-2,000
Closed -$264K
HOFT icon
150
Hooker Furnishings Corp
HOFT
$166M
-20,000
Closed -$379K

Similar funds

Paradigm Capital Management Inc's Q2 2022 Portfolio in Review

As of Q2 2022, Paradigm Capital Management Inc held 155 positions worth $1.47B, down 20% from $1.85B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Paradigm Capital Management Inc's Q2 2022 filing shows 2 new, 28 increased, 47 reduced and 7 closed positions. Its largest new stake was CalAmp Corp.: 19,091 shares worth $1.83M. The largest sale was Lumentum, an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 57% of assets, down from 59% a quarter earlier, followed by Industrials and Healthcare.

  • Paradigm Capital Management Inc's largest Q2 2022 buy was CalAmp Corp.: 19,091 shares worth $1.83M.
  • Paradigm Capital Management Inc added most to MaxLinear in Q2 2022, an estimated $8.28M increase.
  • Paradigm Capital Management Inc's biggest Q2 2022 reduction was Lumentum, cutting an estimated $12.7M.
  • Paradigm Capital Management Inc fully exited Match Group in Q2 2022, selling an estimated $1.89M.
  • Paradigm Capital Management Inc's ten largest holdings make up 36% of its $1.47B portfolio in Q2 2022.
  • Paradigm Capital Management Inc opened 2 new positions and closed 7 in Q2 2022.
  • Paradigm Capital Management Inc's portfolio value fell 20% quarter-over-quarter to $1.47B.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2022, filed 2 Aug 2022.